News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,406 Results
Type
Article (5017)
Company Profile (17)
Press Release (220372)
Section
Business (82200)
Career Advice (461)
Deals (15043)
Drug Delivery (8)
Drug Development (19061)
Employer Resources (30)
FDA (3676)
Job Trends (3901)
News (120105)
Policy (7503)
Tag
Academia (292)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14777)
ALS (20)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (11)
Approvals (3695)
Artificial intelligence (43)
Autoimmune disease (3)
Automation (3)
Bankruptcy (97)
Best Places to Work (2862)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (10)
Brain cancer (7)
Breast cancer (48)
Cancer (456)
Cardiovascular disease (24)
Career advice (393)
Career pathing (3)
CAR-T (33)
Cell therapy (107)
Cervical cancer (2)
Clinical research (16040)
Collaboration (172)
Compensation (172)
Complete response letters (2)
COVID-19 (301)
CRISPR (8)
C-suite (110)
Cystic fibrosis (16)
Data (526)
Depression (7)
Diabetes (43)
Diagnostics (2042)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40912)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37831)
Executive appointments (315)
FDA (3940)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (185)
Gene editing (16)
Generative AI (2)
Gene therapy (53)
GLP-1 (109)
Government (412)
Guidances (21)
Healthcare (5035)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (317)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7825)
IRA (3)
Job creations (1121)
Job search strategy (360)
Kidney cancer (7)
Labor market (5)
Layoffs (100)
Leadership (5)
Legal (2332)
Liver cancer (17)
Lung cancer (54)
Lymphoma (32)
Management (10)
Manufacturing (50)
MASH (29)
Medical device (3862)
Medtech (3863)
Mergers & acquisitions (7426)
Metabolic disorders (125)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (345)
NextGen: Class of 2025 (1674)
Non-profit (727)
Now hiring (3)
Obesity (53)
Opinion (30)
Ovarian cancer (17)
Pain (14)
Pancreatic cancer (14)
Parkinson's disease (28)
Partnered (4)
Patents (21)
Patient recruitment (33)
Peanut (5)
People (24609)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4783)
Phase II (6964)
Phase III (5551)
Pipeline (577)
Policy (9)
Postmarket research (625)
Preclinical (1873)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (70)
Real estate (1874)
Recruiting (8)
Regulatory (5127)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (4)
Schizophrenia (21)
Series A (28)
Series B (23)
Sickle cell disease (7)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (4)
Startups (1009)
Stomach cancer (1)
Supply chain (10)
Tariffs (5)
Vaccines (37)
Venture capitalists (2)
Weight loss (22)
Women's health (1)
Date
Today (58)
Last 7 days (237)
Last 30 days (711)
Last 365 days (9913)
2025 (3223)
2024 (11027)
2023 (13195)
2022 (18658)
2021 (19678)
2020 (18238)
2019 (13205)
2018 (10205)
2017 (10001)
2016 (9156)
2015 (12120)
2014 (9587)
2013 (7707)
2012 (8330)
2011 (8796)
2010 (8634)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11462)
Australia (1611)
California (1993)
Canada (716)
China (73)
Colorado (84)
Connecticut (97)
Delaware (30)
Europe (24542)
Florida (287)
Georgia (34)
Idaho (23)
Illinois (117)
India (7)
Indiana (64)
Iowa (2)
Japan (75)
Kansas (24)
Kentucky (11)
Louisiana (5)
Maine (40)
Maryland (226)
Massachusetts (1596)
Michigan (86)
Minnesota (141)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (16)
New Jersey (576)
New Mexico (5)
New York (480)
North Carolina (332)
North Dakota (3)
Northern California (950)
Ohio (60)
Oklahoma (5)
Oregon (4)
Pennsylvania (353)
Puerto Rico (1)
Rhode Island (13)
South America (276)
South Carolina (6)
Southern California (719)
Tennessee (40)
Texas (230)
United States (7208)
Utah (61)
Virginia (46)
Washington D.C. (9)
Washington State (176)
West Virginia (2)
Wisconsin (25)
225,406 Results for "genelux corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference
May 1, 2025
·
2 min read
Press Releases
Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock
March 26, 2025
·
4 min read
Press Releases
Genelux Corporation Announces New Chief Financial Officer
February 3, 2025
·
4 min read
Press Releases
Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 31, 2025
·
15 min read
Press Releases
Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright
December 13, 2024
·
1 min read
Biotech Beach
Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants
Genelux Corporation, a late clinical-stage immuno-oncology company, announced that it has commenced an underwritten public offering of its common stock and accompanying warrants.
May 23, 2024
·
4 min read
Press Releases
Genelux Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec in Platinum Resistant/Refractory Disease
March 26, 2025
·
6 min read
Press Releases
Genelux and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer
March 26, 2025
·
9 min read
Business
Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates
Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the first quarter of 2024 and provided general business updates.
May 9, 2024
·
8 min read
Press Releases
Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference
November 7, 2024
·
1 min read
1 of 22,541
Next
